ÂÑ°×ÖÊ·ºËØ»¯(Ubiquitination)ÊÇÂÑ°×ÖÊÔÚһϵÁÐÌØÊâøµÄ×÷ÓÃÏ£¬±»·ºËØ£¨ubiquitin, 76¸ö°±»ùËá×é³ÉµÄ¶àëÄ£©¹²¼ÛÐÞÊεÄÀú³Ì£¬·ºËØ-ÂÑ°×øϵһÇн鵼ÁËÕæºËÉúÎï80%¡«90%ÂÑ°×ÖʵĽµ½â£¬ÔÚÏÕЩËùÓеÄÕæºËϸ°ûÔ˶¯ÖÐÆð×ÅÒªº¦×÷Óã¬ÊÇÒ»ÖÖÖ÷ÒªµÄ·ÒëºóÐÞÊΡ£
- ·ºËØ-ÂÑ°×øÌå½µ½âͨ·¼ÓÈëµÄÖÖÖÖÐÄÀíÀú³ÌÑо¿
- ·ºËØ-ÂÑ°×øÌå½µ½âͨ·µ÷¿ØÒì³£ÒýÆð¼²²¡µÄ±¬·¢µÈÑо¿
? ϸ°ûÖÜÆÚ(Cell cycle progression)£¬Ï¸°ûµòÍö(Apoptosis)
? ת¼µ÷¿Ø(Transcriptional regulation)£¬ DNAÐÞ¸´(DNA repair)
? ÃâÒßÓ¦´ð(Immune response)
? ·ºËØÂÑ°×¾»î»¯ºóÌØÒìÐÔÅþÁ¬¾¿¾¹ÎïÂÑ°×ÉÏ
? µ×ÎïÂÑ°×±»ÂÑ°×øÌå½µ½â
? ·ºËØÂÑ°×½ÓÄÉʹÓÃ
·ºËØ»¯Àú³Ì
CST·ºËØ»¯ëĸ»¼¯¿¹Ì壺Ubiquitin Remnant Motif (K-¦Å-GG) Kit #14482
? ²úÆ·ÀàÐÍ
·ºËØ»¯ÐÞÊÎÂÑ°××éѧ
? ÒÇÆ÷ƽ̨
Orbitrap ϵÁÐ, Thermo/Tims TOF Pro2, Bruker
? ËÑ¿âÈí¼þ
Proteome Discoverer / MaxQuant
? Ñù±¾ÒªÇó
ϸ°û¡¢Î¢ÉúÎ1¡Á108 cells/sample
ѪÇ塢Ѫ½¬£º1.5 mL/sample
¶¯Îï¼°ÁÙ´²×éÖ¯±ê±¾£º2 g/sample
Ö²ÎïÄÛÒ¶¡¢ÄÛÑ¿£º10 g/sample
Ö²ÎïÖÖ×Ó¡¢¹ûʵ£º20 g/sample
Òºµª»ò-80¡ãCÉúÑÄ
×ãÁ¿¸É±ùÔËÊ䣬×èÖ¹Öظ´¶³ÈÚ
? Integrative proteomics reveals an increase in non-degradative ubiquitylation in activated CD4+ T cells
ÆÚ¿¯£º Nat Immunol
Ó°ÏìÒò×Ó£º 23.53
ÊÖÒÕÒªÁ죺 ·ºËØ»¯ÐÞÊζ¨Á¿ÂÑ°××é¡¢ÂÑ°××顢ת¼×é
? Ñо¿ÄÚÈÝ
Ô½À´Ô½¶àµÄÖ¤¾ÝÅú×¢·ºËØ»¯¿ÉÒÔÖ±½Óµ¼Ö·ǽµ½âÐÔµÄЧ¹û£¬µ«´ó´ó¶¼¹ØÓÚTϸ°û·ºËØ»¯µÄÑо¿¶¼¼¯ÖÐÔÚ½µ½âÉÏ¡£±¾ÎÄ×÷Õßͨ¹ýÕûºÏСÊóÔ´úCD4+Tϸ°ûµÄÂÑ°×ÖÊ×éºÍת¼×éÊý¾Ý£¬½¨ÉèÒ»¸ö¿ò¼ÜÀ´Õ¹Íû·ºËØ»¯ÒýÆðµÄ½µ½âÐÔ»ò·Ç½µ½âÐÔЧ¹û¡£¶þ¸Ê°±Ëá²Ð»ùÆÊÎöÓÃÓÚÕ¹ÏÖ·ºËØ»¯µÄÂÑ°×ÖÊ£¬ÍŽáȫϸ°ûÂÑ°×ÖÊ×éºÍת¼×éÊý¾Ý¿ÉÒÔÕ¹ÍûÂÑ°×ÖʵĽµ½â¡£Í¨¹ý¶þ¸Ê°±Ëá²Ð»ù·¨ÅжϷºËØ»¯ÂÑ°×µÄÆÊÎöÅú×¢£¬CD4+Tϸ°ûµÄ¼¤»îµ¼Ö·ǽµ½âÐÔ·ºËØ»¯µÄÔöÌí¡£ÕâÓë·ÇÂÑ°×øÌå°ÐÏòµÄK29¡¢K33ºÍK63¶à·ºËØÁ´µÄÔöÌíÓйء£±¾ÏîÑо¿Õ¹ÏÖÁË1,200¶àÖÖÂÑ°×ÖÊÔÚСÊóÔ´úCD4+Tϸ°ûÖзºËØ»¯£¬²¢Ç¿µ÷ÁË·ÇÂÑ°×øÌå°ÐÏò·ºËØÁ´ÔÚTϸ°ûÐźÅתµ¼ÖеÄÏà¹ØÐÔ¡£
? ÊÖÒÕõ辶
? ʵÑéЧ¹û
? Central Role of Ubiquitination in Wheat Response to CWMV Infection
ÆÚ¿¯£º Viruses
Ó°ÏìÒò×Ó£º 5.818
ÊÖÒÕÒªÁ죺 ·ºËØ»¯ÐÞÊÎÂÑ°×ÖÊ×éѧ
? Ñо¿ÄÚÈÝ
·ºËØ»¯ÊÇÒ»ÖÖÖ÷ÒªµÄ·ÒëºóÐÞÊÎ(Post©\translationmodification, PTM)ÀàÐÍ£¬ÏÕЩ¼ÓÈëÁËËùÓÐÕæºËÉúÎïµÄÉúÎïѧÀú³Ì£¬ÔÚÖ²Îï¶Ô²¡ÔÌåÇÖȾµÄ·´Ó¦ÖÐÆð×ÅÖÁ¹ØÖ÷ÒªµÄ×÷Óá£È»¶ø£¬Æù½ñΪֹ£¬ºÜÉÙÓдó¹æÄ£ÆÊÎö²¡ÔÌ壨ÌØÊâÊDz¡¶¾£©ÓÕµ¼µÄСÂó·ºËØ»¯ÐÞÊεÄʵÀý¡£¸ÃÑо¿ÍŽáÖÊÆ×ÆÊÎöÅжÏÁ˼ÓÈëCWMVѬȾµÄ·ºËØ»¯ÂÑ°×£¬Ê¹ÓÃÉúÎïÐÅϢѧ½øÒ»²½ÆÊÎöÁËÕâЩ·ºËØ»¯ÂÑ°×µÄDZÔÚÉúÎïѧ¹¦Ð§¡£
ÔÚѬȾCWMVµÄСÂóÖ²ÖêÖУ¬¹²Åжϳö1255¸ö·ºËØ»¯ÂÑ°×£¬2297¸öÀµ°±Ëá·ºËØ»¯Î»µã£¬ÆäÖÐ192¸öÂÑ°×ÖÊÖÐ350¸öÀµ°±Ëá·ºËØ»¯Î»µã±£´æ±í´ï²î±ð¡£ÕâЩ²î±ðÂÑ°×ÖÊÔÚвÆȺͼ¤ËØ¡¢Ö²Îï-²¡ÔÌåÏ໥×÷Óõȴúл;¾¶ÖнøÒ»²½¸»¼¯¡£±ðµÄ£¬ÔÚCWMVѬȾÀú³ÌÖУ¬ÏÈÌìÐÔÃâÒßϵͳµÄÒªº¦Ta14-3-3ºÍTaHSP90ÏÔÖøÔöÇ¿£¬Åú×¢·ºËØ»¯ÐÞÊÎÔÚCWMVѬȾµÄµ÷¿ØÍøÂçÖÐÆð×ÅÖÁ¹ØÖ÷ÒªµÄ×÷Óá£
? ÊÖÒÕõ辶
? ʵÑéЧ¹û
ÐÞÊÎÍƼö¼Æ»®
ÏÂÔØ×ÊÁÏ°ü | »ñÈ¡±¨¼Û |